Joy Bessenger
Director Financiero/CFO en TRELLUS HEALTH PLC .
Cargos activos de Joy Bessenger
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TRELLUS HEALTH PLC | Director Financiero/CFO | 18/09/2023 | - |
Historial de carrera de Joy Bessenger
Antiguos cargos conocidos de Joy Bessenger.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IMV INC. | Contacto de Relaciones con Inversores | 01/09/2021 | 11/06/2022 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Public Communications Contact | 26/06/2009 | - |
Formación de Joy Bessenger.
| University of South Florida | Undergraduate Degree |
Estadísticas
Internacional
| Islandia | 2 |
| Canadá | 2 |
| Estados Unidos | 2 |
Operativa
| Public Communications Contact | 1 |
| Investor Relations Contact | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IMV INC. | Health Technology |
| TRELLUS HEALTH PLC | Technology Services |
| Empresas privadas | 1 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Bolsa de valores
- Insiders
- Joy Bessenger
- Experiencia